CLINICAL_TRIALS
trial_result
· 2023-04-20
Clinical Trial Update: Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease [Phase 3]
Summary
Phase 3 trial results for trientine tetrahydrochloride in Wilson disease have been completed, with results posted in April 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Orphalan | Conditions: Wilson Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-04-20